Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil

Detalhes bibliográficos
Autor(a) principal: Filho, Luiz Amorim
Data de Publicação: 2020
Outros Autores: Szwarcwald, Celia Landmann, Mateos, Sheila de Oliveira Garcia, Leon, Antonio Carlos Monteiro Ponce de, Medronho, Roberto de Andrade, Veloso, Valdiléa G., Lopes, Josiane Iole França, Porto, Luis Cristovão de Moraes Sobrino, Chieppe, Alexandre, Werneck, Guilherme Loureiro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/43406
Resumo: Grupo Hemorio de Pesquisa em Covid-19: Maria Esther Duarte Lopes, Margarida Pêcego, Orlando Carlos da Conceição Neto, Carlos Alexandre da Costa Silva, Joana Almeida Borges, Gabrielle Tantos Nunes, Larissa Brasil Skaf, Luiz Paulo Teixeira dos Santos, Andrea Rabello, Carla Boquimpani, Rodrigo Guimarães.
id CRUZ_508e1045bbcca9e21a2cf1c983835b25
oai_identifier_str oai:www.arca.fiocruz.br:icict/43406
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Filho, Luiz AmorimSzwarcwald, Celia LandmannMateos, Sheila de Oliveira GarciaLeon, Antonio Carlos Monteiro Ponce deMedronho, Roberto de AndradeVeloso, Valdiléa G.Lopes, Josiane Iole FrançaPorto, Luis Cristovão de Moraes SobrinoChieppe, AlexandreWerneck, Guilherme Loureiro2020-09-16T18:19:05Z2020-09-16T18:19:05Z2020AMORIM FILHO, Luiz et al. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Revista de Saúde Pública, São Paulo, v. 54, 69, p. 1-10, 2020.1518-8787https://www.arca.fiocruz.br/handle/icict/4340610.11606/s1518-8787.2020054002643Grupo Hemorio de Pesquisa em Covid-19: Maria Esther Duarte Lopes, Margarida Pêcego, Orlando Carlos da Conceição Neto, Carlos Alexandre da Costa Silva, Joana Almeida Borges, Gabrielle Tantos Nunes, Larissa Brasil Skaf, Luiz Paulo Teixeira dos Santos, Andrea Rabello, Carla Boquimpani, Rodrigo Guimarães.Authors’ Contribution: LAF: survey conceptualization and execution, coordination of data collection, interpretation of serological results, and conception, draft, review and revision of the article’s intellectual content. CLS: survey conceptualization, statistical analyses, and conception, draft, review and revision of the article’s intellectual content. SOGM: supervision of data collection, interpretation of serological results, and revision of the article’s intellectual content. ACMPL: survey conceptualization, review and revision of the article’s intellectual content. RAM: survey conceptualization, review and revision of the article’s intellectual content. VGV: survey conceptualization, review and revision of the article’s intellectual content. JIFL: supervision of PCR exeution, interpretation of PCR results, and revision of the article’s intellectual content. LCMSP: survey conceptualization, review and revision of the article’s intellectual content. AC: survey conceptualization and execution, review and revision of the article’s intellectual content. GLW: survey conceptualization, conception, draft, review, revision of the article’s intellectual content, and final version (review & editing). All authors read and approved the final version of the manuscript.Hemorio. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Comunicação e Informação Científica e Tecnológica em Saúde. Rio de Janeiro, RJ, Brasil.Hemorio. Rio de Janeiro, RJ, Brasil / Universidade de São Paulo. Faculdade de Medicina da Universidade de São Paulo. São Paulo, SP, Brasil.Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Rio de Janeiro, RJ, Brasil.Universidade do Federal do Rio de Janeiro. Faculdade de Medicina. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Faculdade de Medicina da Universidade de São Paulo. São Paulo, SP, Brasil.Universidade do Estado do Rio de Janeiro. Laboratório de Histocompatibilidade e Criopreservação, Policlínica Piquet Carneiro. Rio de Janeiro, RJ, Brasil.Secretaria de Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.Universidade do Federal do Rio de Janeiro. Instituto de Estudos em Saúde Coletiva. Rio de Janeiro, Brasil.OBJECTIVE: To estimate the seroprevalence of antibodies to SARS-CoV-2 among blood donors in the state of Rio de Janeiro, Brazil. METHODS: Data were collected on 2,857 blood donors from April 14 to 27, 2020. This study reports crude prevalence of antibodies to SARS-CoV-2, population weighted prevalence for the state, and prevalence adjusted for test sensitivity and specificity. Logistic regression models were used to establish the correlates of SARS-CoV-2 prevalence. For the analysis, we considered collection period and site, sociodemographic characteristics, and place of residence. RESULTS: The proportion of positive tests for SARS-Cov-2, without any adjustment, was 4.0% (95%CI 3.3–4.7%), and the weighted prevalence was 3.8% (95%CI 3.1–4.5%). We found lower estimates after adjusting for test sensitivity and specificity: 3.6% (95%CI 2.7–4.4%) for the non-weighted prevalence, and 3.3% (95%CI 2.6–4.1%) for the weighted prevalence. Collection period was the variable most significantly associated with crude prevalence: the later the period, the higher the prevalence. Regarding sociodemographic characteristics, the younger the blood donor, the higher the prevalence, and the lower the education level, the higher the odds of testing positive for SARS-Cov-2 antibody. We found similar results for weighted prevalence. CONCLUSIONS: Our findings comply with some basic premises: the increasing trend over time, as the epidemic curve in the state is still on the rise; and the higher prevalence among both the youngest, for moving around more than older age groups, and the less educated, for encountering more difficulties in following social distancing recommendations. Despite the study limitations, we may infer that Rio de Janeiro is far from reaching the required levels of herd immunity against SARS-CoV-2.engFaculdade de Saúde Pública da Universidade de São PauloSeroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCoronavirus InfectionsimmunologyBlood DonorsSerologic TestsSeroepidemiologic StudiesCOVID-19SARS-CoV-2Infecções por Coronavirusinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83132https://www.arca.fiocruz.br/bitstream/icict/43406/1/license.txt70425d8cb6e40fdcf4edd2ef0660b45bMD51ORIGINAL1518-8787-rsp-54-69[1].pdf1518-8787-rsp-54-69[1].pdfapplication/pdf261073https://www.arca.fiocruz.br/bitstream/icict/43406/2/1518-8787-rsp-54-69%5b1%5d.pdf4ddc94061c564b3702ab713baab08603MD52TEXT1518-8787-rsp-54-69[1].pdf.txt1518-8787-rsp-54-69[1].pdf.txtExtracted texttext/plain35387https://www.arca.fiocruz.br/bitstream/icict/43406/3/1518-8787-rsp-54-69%5b1%5d.pdf.txte0ac4421be99b5612358213524a8cf3eMD53icict/434062023-08-23 14:11:44.265oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-08-23T17:11:44Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
spellingShingle Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
Filho, Luiz Amorim
Coronavirus Infections
immunology
Blood Donors
Serologic Tests
Seroepidemiologic Studies
COVID-19
SARS-CoV-2
Infecções por Coronavirus
title_short Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_full Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_fullStr Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_full_unstemmed Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_sort Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
author Filho, Luiz Amorim
author_facet Filho, Luiz Amorim
Szwarcwald, Celia Landmann
Mateos, Sheila de Oliveira Garcia
Leon, Antonio Carlos Monteiro Ponce de
Medronho, Roberto de Andrade
Veloso, Valdiléa G.
Lopes, Josiane Iole França
Porto, Luis Cristovão de Moraes Sobrino
Chieppe, Alexandre
Werneck, Guilherme Loureiro
author_role author
author2 Szwarcwald, Celia Landmann
Mateos, Sheila de Oliveira Garcia
Leon, Antonio Carlos Monteiro Ponce de
Medronho, Roberto de Andrade
Veloso, Valdiléa G.
Lopes, Josiane Iole França
Porto, Luis Cristovão de Moraes Sobrino
Chieppe, Alexandre
Werneck, Guilherme Loureiro
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Filho, Luiz Amorim
Szwarcwald, Celia Landmann
Mateos, Sheila de Oliveira Garcia
Leon, Antonio Carlos Monteiro Ponce de
Medronho, Roberto de Andrade
Veloso, Valdiléa G.
Lopes, Josiane Iole França
Porto, Luis Cristovão de Moraes Sobrino
Chieppe, Alexandre
Werneck, Guilherme Loureiro
dc.subject.en.pt_BR.fl_str_mv Coronavirus Infections
immunology
Blood Donors
Serologic Tests
Seroepidemiologic Studies
COVID-19
SARS-CoV-2
topic Coronavirus Infections
immunology
Blood Donors
Serologic Tests
Seroepidemiologic Studies
COVID-19
SARS-CoV-2
Infecções por Coronavirus
dc.subject.decs.pt_BR.fl_str_mv Infecções por Coronavirus
description Grupo Hemorio de Pesquisa em Covid-19: Maria Esther Duarte Lopes, Margarida Pêcego, Orlando Carlos da Conceição Neto, Carlos Alexandre da Costa Silva, Joana Almeida Borges, Gabrielle Tantos Nunes, Larissa Brasil Skaf, Luiz Paulo Teixeira dos Santos, Andrea Rabello, Carla Boquimpani, Rodrigo Guimarães.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-09-16T18:19:05Z
dc.date.available.fl_str_mv 2020-09-16T18:19:05Z
dc.date.issued.fl_str_mv 2020
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv AMORIM FILHO, Luiz et al. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Revista de Saúde Pública, São Paulo, v. 54, 69, p. 1-10, 2020.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/43406
dc.identifier.issn.pt_BR.fl_str_mv 1518-8787
dc.identifier.doi.none.fl_str_mv 10.11606/s1518-8787.2020054002643
identifier_str_mv AMORIM FILHO, Luiz et al. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Revista de Saúde Pública, São Paulo, v. 54, 69, p. 1-10, 2020.
1518-8787
10.11606/s1518-8787.2020054002643
url https://www.arca.fiocruz.br/handle/icict/43406
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/43406/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/43406/2/1518-8787-rsp-54-69%5b1%5d.pdf
https://www.arca.fiocruz.br/bitstream/icict/43406/3/1518-8787-rsp-54-69%5b1%5d.pdf.txt
bitstream.checksum.fl_str_mv 70425d8cb6e40fdcf4edd2ef0660b45b
4ddc94061c564b3702ab713baab08603
e0ac4421be99b5612358213524a8cf3e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008877616103424

Registros relacionados